Lung Cancer Diagnostics Market Forecast, Trend Analysis & Competition Tracking: Global Market insights 2021 to 2031

Aug 2021| FMR1294A| Fact Market Research

Report Highlights

Lung Cancer Diagnostics Market- Scope of Report

A recent study by Fact.MR on the lung cancer diagnostics market offers a 10-year forecast for 2021 to 2031. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with the manufacturing of the lung cancer diagnostics market.

The study also provides the dynamics responsible for influencing the future status of the lung cancer diagnostics market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the lung cancer diagnostics market, along with their product portfolios, enhances the reliability of this comprehensive research study.

Report Summary

The study offers a comprehensive analysis of diverse features, including production capacities, demand, product developments, revenue generation, and sales of the lung cancer diagnostics market across the globe.

A comprehensive estimate of the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of the lung cancer diagnostics market during the forecast period. Price point comparison by region with the global average price is also considered in the study.

Key Questions Answered in Report

  • Which are the most lucrative lung cancer diagnostics markets?
  • Which factors will impact the growth of lung cancer diagnostics?
  • How will changing trends impact the strategies of market players?
  • How can market players capture the low-hanging opportunities across regions?
  • Which companies are leading the lung cancer diagnostics industry?
  • What are the winning strategies of stakeholders in the market?

Analysis of Market Size Evaluation

The market has been analyzed for each segment in terms of volume (‘000 Units) and value (US$ Mn).

Estimates at global and regional levels for the reinforced thermoplastic market are available in terms of “US$ Mn” for value and in “‘000 Units” for volume. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report. Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global lung cancer diagnostics market.

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which has helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the lung cancer diagnostics market during the forecast period.

Country-specific valuation on demand for lung cancer diagnostics market has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value & volume for emerging countries has also been included in the report.

In-depth Analysis on Competition Analysis

The report sheds light on leading manufacturers of the lung cancer diagnostics market, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in producing lung cancer medicines have been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permit report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which includes essentials such as product portfolios and key strategies, along with an all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the lung cancer diagnostics market domain. 

Research Methodology

In Fact.MR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the lung cancer diagnostics market industry, and reach conclusions on the future growth parameters. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the drawn conclusions.

Secondary resources referred to by analysts during the preparation of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of the research report as a primary resource.

  • Table 1 : Global Lung Cancer Diagnostics Market Value (US$ Mn), 2016-2020 29
  • Table 2 : Global Lung Cancer Diagnostics Market Value (US$ Mn), 2021-2031 30
  • Table 3 : Global Lung Cancer Diagnostics Market Value (US$ Mn) and Y-o-Y, 2015-2031 32
  • Table 4 : Global CA Test Segment Value (US$ Mn), By Region 2016-2020 34
  • Table 5 : Global CA Test Segment Value (US$ Mn), By Region 2021-2031 35
  • Table 6 : Global CA Test Segment Market Share, By Region 2016-2020 36
  • Table 7 : Global CA Test Segment Market Share, By Region 2021-2031 36
  • Table 8 : Global CA Test Segment Y-o-Y, By Region 2015-2031 36
  • Table 9 : Global HER2 Tests Segment Value (US$ Mn), By Region 2016-2020 37
  • Table 10 : Global HER2 Tests Segment Value (US$ Mn), By Region 2021-2031 38
  • Table 11 : Global HER2 Tests Segment Market Share, By Region 2016-2020 39
  • Table 12 : Global HER2 Tests Segment Market Share, By Region 2021-2031 39
  • Table 13 : Global HER2 Tests Segment Y-o-Y, By Region 2015-2031 39
  • Table 14 : Global ALK Tests Segment Value (US$ Mn), By Region 2016-2020 40
  • Table 15 : Global ALK Tests Segment Value (US$ Mn), By Region 2021-2031 41
  • Table 16 : Global ALK Tests Segment Market Share, By Region 2016-2020 42
  • Table 17 : Global ALK Tests Segment Market Share, By Region 2021-2031 42
  • Table 18 : Global ALK Tests Segment Y-o-Y, By Region 2015-2031 42
  • Table 19 : Global Angiogenesis Inhibitor Segment Value (US$ Mn), By Region 2016-2020 43
  • Table 20 : Global Angiogenesis Inhibitor Segment Value (US$ Mn), By Region 2021-2031 44
  • Table 21 : Global Angiogenesis Inhibitor Segment Market Share, By Region 2016-2020 45
  • Table 22 : Global Angiogenesis Inhibitor Segment Market Share, By Region 2021-2031 45
  • Table 23 : Global Angiogenesis Inhibitor Segment Y-o-Y, By Region 2015-2031 45
  • Table 24 : Global EGFR Mutation Tests Segment Value (US$ Mn), By Region 2016-2020 46
  • Table 25 : Global EGFR Mutation Tests Segment Value (US$ Mn), By Region 2021-2031 47
  • Table 26 : Global EGFR Mutation Tests Segment Market Share, By Region 2016-2020 48
  • Table 27 : Global EGFR Mutation Tests Segment Market Share, By Region 2021-2031 48
  • Table 28 : Global EGFR Mutation Tests Segment Y-o-Y, By Region 2015-2031 48
  • Table 29 : Global KRAS Mutation Tests Segment Value (US$ Mn), By Region 2016-2020 49
  • Table 30 : Global KRAS Mutation Tests Segment Value (US$ Mn), By Region 2021-2031 50
  • Table 31 : Global KRAS Mutation Tests Segment Market Share, By Region 2016-2020 51
  • Table 32 : Global KRAS Mutation Tests Segment Market Share, By Region 2021-2031 51
  • Table 33 : Global KRAS Mutation Tests Segment Y-o-Y, By Region 2015-2031 51
  • Table 34 : Global Others Segment Value (US$ Mn), By Region 2016-2020 52
  • Table 35 : Global Others Segment Value (US$ Mn), By Region 2021-2031 53
  • Table 36 : Global Others Segment Market Share, By Region 2016-2020 54
  • Table 37 : Global Others Segment Market Share, By Region 2021-2031 54
  • Table 38 : Global Others Segment Y-o-Y, By Region 2015-2031 54
  • Table 39 : Global Hospital Associated Labs Segment Value (US$ Mn), By Region 2016-2020 56
  • Table 40 : Global Hospital Associated Labs Segment Value (US$ Mn), By Region 2021-2031 57
  • Table 41 : Global Hospital Associated Labs Segment Market Share, By Region 2016-2020 58
  • Table 42 : Global Hospital Associated Labs Segment Market Share, By Region 2021-2031 58
  • Table 43 : Global Hospital Associated Labs Segment Y-o-Y, By Region 2015-2031 58
  • Table 44 : Global Independent Diagnostic Laboratories Segment Value (US$ Mn), By Region 2016-2020 59
  • Table 45 : Global Independent Diagnostic Laboratories Segment Value (US$ Mn), By Region 2021-2031 60
  • Table 46 : Global Independent Diagnostic Laboratories Segment Market Share, By Region 2016-2020 61
  • Table 47 : Global Independent Diagnostic Laboratories Segment Market Share, By Region 2021-2031 61
  • Table 48 : Global Independent Diagnostic Laboratories Segment Y-o-Y, By Region 2015-2031 61
  • Table 49 : Global Cancer Research Institutes Segment Value (US$ Mn), By Region 2016-2020 62
  • Table 50 : Global Cancer Research Institutes Segment Value (US$ Mn), By Region 2021-2031 63
  • Table 51 : Global Cancer Research Institutes Segment Market Share, By Region 2016-2020 64
  • Table 52 : Global Cancer Research Institutes Segment Market Share, By Region 2021-2031 64
  • Table 53 : Global Cancer Research Institutes Segment Y-o-Y, By Region 2015-2031 64
  • Table 54 : Global Others Segment Value (US$ Mn), By Region 2016-2020 65
  • Table 55 : Global Others Segment Value (US$ Mn), By Region 2021-2031 66
  • Table 56 : Global Others Segment Market Share, By Region 2016-2020 67
  • Table 57 : Global Others Segment Market Share, By Region 2021-2031 67
  • Table 58 : Global Others Segment Y-o-Y, By Region 2015-2031 67
  • Table 59 : Global Non Small-cell Lung Cancer Segment Value (US$ Mn), By Region 2016-2020 69
  • Table 60 : Global Non Small-cell Lung Cancer Segment Value (US$ Mn), By Region 2021-2031 70
  • Table 61 : Global Non Small-cell Lung Cancer Segment Market Share, By Region 2016-2020 71
  • Table 62 : Global Non Small-cell Lung Cancer Segment Market Share, By Region 2021-2031 71
  • Table 63 : Global Non Small-cell Lung Cancer Segment Y-o-Y, By Region 2015-2031 71
  • Table 64 : Global Small-cell Lung Cancer Segment Value (US$ Mn), By Region 2016-2020 72
  • Table 65 : Global Small-cell Lung Cancer Segment Value (US$ Mn), By Region 2021-2031 73
  • Table 66 : Global Small-cell Lung Cancer Segment Market Share, By Region 2016-2020 74
  • Table 67 : Global Small-cell Lung Cancer Segment Market Share, By Region 2021-2031 74
  • Table 68 : Global Small-cell Lung Cancer Segment Y-o-Y, By Region 2015-2031 74
  • Table 69 : North America Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 76
  • Table 70 : North America Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 77
  • Table 71 : North America Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 78
  • Table 72 : North America Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 78
  • Table 73 : North America Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 79
  • Table 74 : North America Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 80
  • Table 75 : Latin America Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 81
  • Table 76 : Latin America Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 82
  • Table 77 : Latin America Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 83
  • Table 78 : Latin America Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 83
  • Table 79 : Latin America Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 84
  • Table 80 : Latin America Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 85
  • Table 81 : Europe Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 86
  • Table 82 : Europe Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 87
  • Table 83 : Europe Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 88
  • Table 84 : Europe Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 88
  • Table 85 : Europe Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 89
  • Table 86 : Europe Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 90
  • Table 87 : Japan Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 91
  • Table 88 : Japan Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 92
  • Table 89 : Japan Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 93
  • Table 90 : Japan Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 93
  • Table 91 : Japan Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 94
  • Table 92 : Japan Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 95
  • Table 93 : APEJ Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 96
  • Table 94 : APEJ Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 97
  • Table 95 : APEJ Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 98
  • Table 96 : APEJ Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 98
  • Table 97 : APEJ Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 99
  • Table 98 : APEJ Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 100
  • Table 99 : MEA Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 101
  • Table 100 : MEA Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 102
  • Table 101 : MEA Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 103
  • Table 102 : MEA Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 103
  • Table 103 : MEA Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 104
  • Table 104 : MEA Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 105
  • Table 105 : US Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 107
  • Table 106 : US Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 107
  • Table 107 : US Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 108
  • Table 108 : US Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 108
  • Table 109 : US Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 108
  • Table 110 : US Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 109
  • Table 111 : Canada Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 109
  • Table 112 : Canada Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 110
  • Table 113 : Canada Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 110
  • Table 114 : Canada Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 111
  • Table 115 : Canada Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 111
  • Table 116 : Canada Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 111
  • Table 117 : Brazil Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 113
  • Table 118 : Brazil Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 113
  • Table 119 : Brazil Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 114
  • Table 120 : Brazil Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 114
  • Table 121 : Brazil Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 114
  • Table 122 : Brazil Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 115
  • Table 123 : Mexico Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 115
  • Table 124 : Mexico Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 116
  • Table 125 : Mexico Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 116
  • Table 126 : Mexico Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 117
  • Table 127 : Mexico Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 117
  • Table 128 : Mexico Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 117
  • Table 129 : Argentina Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 118
  • Table 130 : Argentina Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 118
  • Table 131 : Argentina Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 119
  • Table 132 : Argentina Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 119
  • Table 133 : Argentina Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 120
  • Table 134 : Argentina Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 120
  • Table 135 : Germany Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 121
  • Table 136 : Germany Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 121
  • Table 137 : Germany Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 122
  • Table 138 : Germany Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 122
  • Table 139 : Germany Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 123
  • Table 140 : Germany Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 123
  • Table 141 : UK Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 123
  • Table 142 : UK Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 124
  • Table 143 : UK Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 124
  • Table 144 : UK Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 125
  • Table 145 : UK Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 125
  • Table 146 : UK Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 125
  • Table 147 : France Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 126
  • Table 148 : France Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 126
  • Table 149 : France Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 127
  • Table 150 : France Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 127
  • Table 151 : France Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 128
  • Table 152 : France Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 128
  • Table 153 : Spain Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 128
  • Table 154 : Spain Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 129
  • Table 155 : Spain Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 129
  • Table 156 : Spain Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 130
  • Table 157 : Spain Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 130
  • Table 158 : Spain Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 130
  • Table 159 : Italy Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 131
  • Table 160 : Italy Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 131
  • Table 161 : Italy Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 132
  • Table 162 : Italy Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 132
  • Table 163 : Italy Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 133
  • Table 164 : Italy Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 133
  • Table 165 : Nordic Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 133
  • Table 166 : Nordic Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 134
  • Table 167 : Nordic Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 134
  • Table 168 : Nordic Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 135
  • Table 169 : Nordic Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 135
  • Table 170 : Nordic Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 135
  • Table 171 : Japan Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 137
  • Table 172 : Japan Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 137
  • Table 173 : Japan Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 138
  • Table 174 : Japan Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 138
  • Table 175 : Japan Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 138
  • Table 176 : Japan Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 139
  • Table 177 : China Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 140
  • Table 178 : China Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 140
  • Table 179 : China Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 141
  • Table 180 : China Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 141
  • Table 181 : China Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 141
  • Table 182 : China Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 142
  • Table 183 : India Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 142
  • Table 184 : India Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 143
  • Table 185 : India Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 143
  • Table 186 : India Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 144
  • Table 187 : India Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 144
  • Table 188 : India Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 144
  • Table 189 : Malaysia Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 145
  • Table 190 : Malaysia Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 145
  • Table 191 : Malaysia Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 146
  • Table 192 : Malaysia Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 146
  • Table 193 : Malaysia Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 147
  • Table 194 : Malaysia Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 147
  • Table 195 : Thailand Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 147
  • Table 196 : Thailand Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 148
  • Table 197 : Thailand Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 148
  • Table 198 : Thailand Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 149
  • Table 199 : Thailand Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 149
  • Table 200 : Thailand Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 149
  • Table 201 : Singapore Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 150
  • Table 202 : Singapore Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 150
  • Table 203 : Singapore Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 151
  • Table 204 : Singapore Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 151
  • Table 205 : Singapore Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 152
  • Table 206 : Singapore Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 152
  • Table 207 : Australia Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 153
  • Table 208 : Australia Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 153
  • Table 209 : Australia Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 154
  • Table 210 : Australia Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 154
  • Table 211 : Australia Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 154
  • Table 212 : Australia Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 155
  • Table 213 : GCC Countries Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 156
  • Table 214 : GCC Countries Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 156
  • Table 215 : GCC Countries Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 157
  • Table 216 : GCC Countries Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 157
  • Table 217 : GCC Countries Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 158
  • Table 218 : GCC Countries Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 158
  • Table 219 : South Africa Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 158
  • Table 220 : South Africa Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 159
  • Table 221 : South Africa Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 159
  • Table 222 : South Africa Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 160
  • Table 223 : South Africa Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 160
  • Table 224 : South Africa Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 160
  • Table 225 : Nigeria Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 161
  • Table 226 : Nigeria Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 161
  • Table 227 : Nigeria Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 162
  • Table 228 : Nigeria Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 162
  • Table 229 : Nigeria Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 163
  • Table 230 : Nigeria Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 163
  • Table 231 : Israel Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 163
  • Table 232 : Israel Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 164
  • Table 233 : Israel Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 164
  • Table 234 : Israel Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 165
  • Table 235 : Israel Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 165
  • Table 236 : Israel Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 165
  • Figure 1 : Global Lung Cancer Diagnostics Market Value (US$ Mn), 2016-2020 18
  • Figure 2 : Global Lung Cancer Diagnostics Market Value (US$ Mn) Forecast, 2021-2031 18
  • Figure 3 : Global Lung Cancer Diagnostics Market Value (US$ Mn) and Y-o-Y, 2015-2031 20
  • Figure 4 : Global CA Test Segment Market Value (US$ Mn) By Region, 2016-2020 22
  • Figure 5 : Global CA Test Segment Market Value (US$ Mn) By Region, 2021-2031 23
  • Figure 6 : Global CA Test Segment Y-o-Y Growth Rate, By Region, 2015-2031 25
  • Figure 7 : Global HER2 Tests Segment Market Value (US$ Mn) By Region, 2016-2020 25
  • Figure 8 : Global HER2 Tests Segment Market Value (US$ Mn) By Region, 2021-2031 26
  • Figure 9 : Global HER2 Tests Segment Y-o-Y Growth Rate, By Region, 2015-2031 28
  • Figure 10 : Global ALK Tests Segment Market Value (US$ Mn) By Region, 2016-2020 28
  • Figure 11 : Global ALK Tests Segment Market Value (US$ Mn) By Region, 2021-2031 29
  • Figure 12 : Global ALK Tests Segment Y-o-Y Growth Rate, By Region, 2015-2031 31
  • Figure 13 : Global Angiogenesis Inhibitor Segment Market Value (US$ Mn) By Region, 2016-2020 31
  • Figure 14 : Global Angiogenesis Inhibitor Segment Market Value (US$ Mn) By Region, 2021-2031 32
  • Figure 15 : Global Angiogenesis Inhibitor Segment Y-o-Y Growth Rate, By Region, 2015-2031 34
  • Figure 16 : Global EGFR Mutation Tests Segment Market Value (US$ Mn) By Region, 2016-2020 34
  • Figure 17 : Global EGFR Mutation Tests Segment Market Value (US$ Mn) By Region, 2021-2031 35
  • Figure 18 : Global EGFR Mutation Tests Segment Y-o-Y Growth Rate, By Region, 2015-2031 37
  • Figure 19 : Global KRAS Mutation Tests Segment Market Value (US$ Mn) By Region, 2016-2020 37
  • Figure 20 : Global KRAS Mutation Tests Segment Market Value (US$ Mn) By Region, 2021-2031 38
  • Figure 21 : Global KRAS Mutation Tests Segment Y-o-Y Growth Rate, By Region, 2015-2031 40
  • Figure 22 : Global Others Segment Market Value (US$ Mn) By Region, 2016-2020 40
  • Figure 23 : Global Others Segment Market Value (US$ Mn) By Region, 2021-2031 41
  • Figure 24 : Global Others Segment Y-o-Y Growth Rate, By Region, 2015-2031 43
  • Figure 25 : Global Hospital Associated Labs Segment Market Value (US$ Mn) By Region, 2016-2020 44
  • Figure 26 : Global Hospital Associated Labs Segment Market Value (US$ Mn) By Region, 2021-2031 45
  • Figure 27 : Global Hospital Associated Labs Segment Y-o-Y Growth Rate, By Region, 2015-2031 47
  • Figure 28 : Global Independent Diagnostic Laboratories Segment Market Value (US$ Mn) By Region, 2016-2020 47
  • Figure 29 : Global Independent Diagnostic Laboratories Segment Market Value (US$ Mn) By Region, 2021-2031 48
  • Figure 30 : Global Independent Diagnostic Laboratories Segment Y-o-Y Growth Rate, By Region, 2015-2031 50
  • Figure 31 : Global Cancer Research Institutes Segment Market Value (US$ Mn) By Region, 2016-2020 50
  • Figure 32 : Global Cancer Research Institutes Segment Market Value (US$ Mn) By Region, 2021-2031 51
  • Figure 33 : Global Cancer Research Institutes Segment Y-o-Y Growth Rate, By Region, 2015-2031 53
  • Figure 34 : Global Others Segment Market Value (US$ Mn) By Region, 2016-2020 53
  • Figure 35 : Global Others Segment Market Value (US$ Mn) By Region, 2021-2031 54
  • Figure 36 : Global Others Segment Y-o-Y Growth Rate, By Region, 2015-2031 56
  • Figure 37 : Global Non Small-cell Lung Cancer Segment Market Value (US$ Mn) By Region, 2016-2020 57
  • Figure 38 : Global Non Small-cell Lung Cancer Segment Market Value (US$ Mn) By Region, 2021-2031 58
  • Figure 39 : Global Non Small-cell Lung Cancer Segment Y-o-Y Growth Rate, By Region, 2015-2031 60
  • Figure 40 : Global Small-cell Lung Cancer Segment Market Value (US$ Mn) By Region, 2016-2020 60
  • Figure 41 : Global Small-cell Lung Cancer Segment Market Value (US$ Mn) By Region, 2021-2031 61
  • Figure 42 : Global Small-cell Lung Cancer Segment Y-o-Y Growth Rate, By Region, 2015-2031 63
  • Figure 43 : North America Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 64
  • Figure 44 : North America Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 65
  • Figure 45 : North America Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 66
  • Figure 46 : North America Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 67
  • Figure 47 : North America Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 68
  • Figure 48 : North America Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 68
  • Figure 49 : Latin America Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 69
  • Figure 50 : Latin America Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 70
  • Figure 51 : Latin America Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 71
  • Figure 52 : Latin America Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 72
  • Figure 53 : Latin America Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 73
  • Figure 54 : Latin America Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 73
  • Figure 55 : Europe Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 74
  • Figure 56 : Europe Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 75
  • Figure 57 : Europe Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 76
  • Figure 58 : Europe Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 77
  • Figure 59 : Europe Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 78
  • Figure 60 : Europe Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 78
  • Figure 61 : Japan Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 79
  • Figure 62 : Japan Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 80
  • Figure 63 : Japan Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 81
  • Figure 64 : Japan Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 82
  • Figure 65 : Japan Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 83
  • Figure 66 : Japan Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 83
  • Figure 67 : APEJ Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 84
  • Figure 68 : APEJ Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 85
  • Figure 69 : APEJ Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 86
  • Figure 70 : APEJ Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 87
  • Figure 71 : APEJ Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 88
  • Figure 72 : APEJ Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 88
  • Figure 73 : MEA Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 89
  • Figure 74 : MEA Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 90
  • Figure 75 : MEA Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 91
  • Figure 76 : MEA Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 92
  • Figure 77 : MEA Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 93
  • Figure 78 : MEA Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 93

Fact.MR is an independent, pure play market intelligence firm incorporated with an objective to deliver high quality, customized market research solutions that help our clients successfully go to the market equipped with actionable insights capable of impacting crucial business decisions.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report